Company Description
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.
The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians.
It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions.
In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions.
It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs.
The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Country | United States |
Founded | 2007 |
IPO Date | Jul 2, 2020 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 2,400 |
CEO | Rajeev Singh |
Contact Details
Address: 1201 Third Avenue, Suite 1700 Seattle, Washington 98101 United States | |
Phone | 206 926 8100 |
Website | accolade.com |
Stock Details
Ticker Symbol | ACCD |
Exchange | NASDAQ |
Fiscal Year | March - February |
Reporting Currency | USD |
IPO Price | $22.00 |
CIK Code | 0001481646 |
CUSIP Number | 00437E102 |
ISIN Number | US00437E1029 |
Employer ID | 43-2117836 |
SIC Code | 7389 |
Key Executives
Name | Position |
---|---|
Rajeev Singh | Chairman of the Board and Chief Executive Officer |
Robert Cavanaugh | President |
Stephen H. Barnes CPA | Chief Financial Officer and Treasurer |
Richard Eskew | Executive Vice President, General Counsel, CCO and Secretary |
Kristen Bruzek | Senior Vice President of Operations |
Colin McHugh | Chief Accounting Officer |
Todd Friedman | Senior Vice President of Investor Relations |
Kelsi McDonald Harris | Chief People Officer and Senior Vice President |
Drew Garner | Executive Vice President of Engineering |
Dr. Shantanu Nundy M.B.A., M.D. | Executive Vice President, Chief Health Officer and Member of the Medical Advisory Board |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 4, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Oct 17, 2024 | 144 | Filing |
Oct 17, 2024 | 144 | Filing |
Oct 17, 2024 | 144 | Filing |
Oct 17, 2024 | 144 | Filing |
Oct 11, 2024 | 144 | Filing |
Oct 11, 2024 | 144 | Filing |
Oct 11, 2024 | 144 | Filing |
Oct 8, 2024 | 10-Q | Quarterly Report |